Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Advanced search   
Search
request
Library

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2 3 4 5
hits: 324,771
1.
  • Risk‐reducing mastectomy fo... Risk‐reducing mastectomy for the prevention of primary breast cancer
    Carbine, Nora E; Lostumbo, Liz; Wallace, Judi ... Cochrane database of systematic reviews, 04/2018, Volume: 2019, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Background Recent progress in understanding the genetic basis of breast cancer and widely publicized reports of celebrities undergoing risk‐reducing mastectomy (RRM) have increased interest in RRM as ...
Full text
Available for: OILJ, UM, UPUK, VSZLJ

PDF
2.
  • Breast cancer-specific mort... Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics
    Nelson, David R; Brown, Jacqueline; Morikawa, Aki ... PloS one, 02/2022, Volume: 17, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    To investigate breast cancer-specific mortality by early breast cancer (EBC; Stages I-IIIC) subtype; incidence of high-risk indicators for recurrence (defined in monarchE trial); and mortality risk ...
Full text
Available for: DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK

PDF
3.
  • US Incidence of Breast Canc... US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
    HOWLADER, Nadia; ALTEKRUSE, Sean F; LI, Christopher I ... JNCI : Journal of the National Cancer Institute, 04/2014, Volume: 106, Issue: 5
    Journal Article
    Peer reviewed
    Open access

    In 2010, Surveillance, Epidemiology, and End Results (SEER) registries began collecting human epidermal growth factor 2 (HER2) receptor status for breast cancer cases. Breast cancer subtypes defined ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
4.
  • Neratinib Plus Capecitabine... Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
    Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun ... Journal of clinical oncology, 09/2020, Volume: 38, Issue: 27
    Journal Article
    Peer reviewed
    Open access

    NALA (ClinicalTrials.gov identifier: NCT01808573) is a randomized, active-controlled, phase III trial comparing neratinib, an irreversible pan-HER tyrosine kinase inhibitor (TKI), plus capecitabine ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
5.
  • Association between CD8+ T-... Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
    Ali, H.R.; Provenzano, E.; Dawson, S.-J. ... Annals of oncology, 08/2014, Volume: 25, Issue: 8
    Journal Article
    Peer reviewed
    Open access

    T-cell infiltration in estrogen receptor (ER)-negative breast tumours has been associated with longer survival. To investigate this association and the potential of tumour T-cell infiltration as a ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
6.
  • Triple-negative breast canc... Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
    Li, Xiaoxian; Yang, Jing; Peng, Limin ... Breast cancer research and treatment, 01/2017, Volume: 161, Issue: 2
    Journal Article
    Peer reviewed

    Purpose The current American Joint Committee on Cancer (AJCC) staging manual uses tumor size, lymph node, and metastatic status to stage breast cancer across different subtypes. We examined the ...
Full text
Available for: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OBVAL, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
7.
  • Bioinformatics analysis of ... Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer
    Zhang, Mingdi; Chen, Hongliang; Wang, Maoli ... Bioscience reports, 02/2020, Volume: 40, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    Collagen type X alpha 1 (COL10A1) is overexpressed in diverse tumors and displays vital roles in tumorigenesis. However, the prognostic value of COL10A1 in breast cancer remains unclear. The ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
8.
  • Annual Report to the Nation... Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
    Kohler, Betsy A; Sherman, Recinda L; Howlader, Nadia ... JNCI : Journal of the National Cancer Institute, 06/2015, Volume: 107, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    The American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), and North American Association of Central Cancer Registries (NAACCR) collaborate ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
9.
  • Breast cancer receptor stat... Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series
    McCormack, Valerie A; Joffe, Maureen; van den Berg, Eunice ... Breast cancer research : BCR, 01/2013, Volume: 15, Issue: 5
    Journal Article
    Peer reviewed
    Open access

    Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (TRN) breast cancer from sub-Saharan Africa are variable and include high values. Large studies of receptor status ...
Full text
Available for: NUK, UL, UM, UPUK, VSZLJ

PDF
10.
  • Impact of breast cancer mol... Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
    Darlix, Amélie; Louvel, Guillaume; Fraisse, Julien ... British journal of cancer, 12/2019, Volume: 121, Issue: 12
    Journal Article
    Peer reviewed
    Open access

    Metastatic breast cancer (MBC) behaviour differs depending on hormone receptors (HR) and human epidermal growth factor receptor (HER2) statuses. The kinetics of central nervous system (CNS) ...
Full text
Available for: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
1 2 3 4 5
hits: 324,771

Load filters